Inter-rater reliability study of the Japanese version of the diagnostic clinical interview for drug withdrawal post SSRIs or SNRIs (DID-W1-J).
作者信息
Nakamura Tomoyuki, Oe Misari, Uematsu Ken, Hori Hikaru, Ozone Motohiro, Cosci Fiammetta
机构信息
Department of Neuropsychiatry Kurume University School of Medicine Kurume Fukuoka Japan.
Uematsu Mental Clinic Chikugo Fukuoka Japan.
出版信息
PCN Rep. 2025 Jan 8;4(1):e70050. doi: 10.1002/pcn5.70050. eCollection 2025 Mar.
Abstract
摘要
相似文献
1
Inter-rater reliability study of the Japanese version of the diagnostic clinical interview for drug withdrawal post SSRIs or SNRIs (DID-W1-J).
PCN Rep. 2025 Jan 8;4(1):e70050. doi: 10.1002/pcn5.70050. eCollection 2025 Mar.
2
The Diagnostic clinical Interview for Drug Withdrawal 1 (DID-W1) – New Symptoms of Selective Serotonin Reuptake Inhibitors (SSRI) or Serotonin Norepinephrine Reuptake Inhibitors (SNRI): inter-rater reliability.
Riv Psichiatr. 2018 Mar-Apr;53(2):95-99. doi: 10.1708/2891.29158.
3
Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reuptake Inhibitors.
J Clin Psychopharmacol. 2022;42(1):17-22. doi: 10.1097/JCP.0000000000001491.
4
Selective Serotonin Reuptake Inhibitor and Serotonin-Noradrenaline Reuptake Inhibitor Withdrawal Changes DSM Presentation of Mental Disorders: Results from the Diagnostic Clinical Interview for Drug Withdrawal.
Psychother Psychosom. 2024;93(5):340-345. doi: 10.1159/000540031. Epub 2024 Jul 23.
5
Feasibility and Inter-rater Reliability of the Japanese Version of the Intensive Care Unit Mobility Scale.
Cureus. 2024 Apr 27;16(4):e59135. doi: 10.7759/cureus.59135. eCollection 2024 Apr.
6
Verifying the Japanese Version of Pediatric Delirium and Withdrawal Syndrome Assessment Scale: SOS-PD Validation Study for Iatrogenic Withdrawal Syndrome.
Children (Basel). 2025 Mar 17;12(3):372. doi: 10.3390/children12030372.
7
The inter-rater reliability of the Japanese version of the Inventory of Depressive Symptomatology, clinician version.
Hum Psychopharmacol. 2011 Apr;26(3):267-9. doi: 10.1002/hup.1201.
8
Reliability, validity, and minimal clinically important differences of the Japanese version of the early clinical assessment of balance in children with cerebral palsy.
Disabil Rehabil. 2022 Nov;44(23):7283-7289. doi: 10.1080/09638288.2021.1977859. Epub 2021 Sep 19.
9
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Cochrane Database Syst Rev. 2015 May 1;2015(5):CD011681. doi: 10.1002/14651858.CD011681.
10
Reliability and consistency of the Japanese version of the Primary Lateral Sclerosis Functional Rating Scale.
BMC Neurol. 2024 Aug 13;24(1):282. doi: 10.1186/s12883-024-03729-6.
本文引用的文献
1
Selective Serotonin Reuptake Inhibitor and Serotonin-Noradrenaline Reuptake Inhibitor Withdrawal Changes DSM Presentation of Mental Disorders: Results from the Diagnostic Clinical Interview for Drug Withdrawal.
Psychother Psychosom. 2024;93(5):340-345. doi: 10.1159/000540031. Epub 2024 Jul 23.
2
Safety profile of antidepressant for Japanese adults with major depressive disorder: A systematic review and network meta-analysis.
Psychiatry Clin Neurosci. 2024 Feb;78(2):142-144. doi: 10.1111/pcn.13622. Epub 2023 Dec 10.
3
Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reuptake Inhibitors.
J Clin Psychopharmacol. 2022;42(1):17-22. doi: 10.1097/JCP.0000000000001491.
4
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications.
Psychother Psychosom. 2020;89(5):283-306. doi: 10.1159/000506868. Epub 2020 Apr 7.
5
Understanding and Managing Withdrawal Syndromes After Discontinuation of Antidepressant Drugs.
J Clin Psychiatry. 2019 Nov 26;80(6):19com12794. doi: 10.4088/JCP.19com12794.
6
Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review.
Psychother Psychosom. 2018;87(4):195-203. doi: 10.1159/000491524. Epub 2018 Jul 17.
7
The Diagnostic clinical Interview for Drug Withdrawal 1 (DID-W1) – New Symptoms of Selective Serotonin Reuptake Inhibitors (SSRI) or Serotonin Norepinephrine Reuptake Inhibitors (SNRI): inter-rater reliability.
Riv Psichiatr. 2018 Mar-Apr;53(2):95-99. doi: 10.1708/2891.29158.
8
New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal.
Psychother Psychosom. 2015;84(2):63-71. doi: 10.1159/000371865. Epub 2015 Feb 21.
9
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57.
10
Antidepressant discontinuation: a review of the literature.
J Clin Psychiatry. 1997;58 Suppl 7:11-5; discussion 16.
Zotero 插件